|Bid||0.00 x 2200|
|Ask||0.00 x 800|
|Day's Range||159.68 - 165.87|
|52 Week Range||151.00 - 190.49|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.26|
|Expense Ratio (net)||0.07%|
After a lackluster July, growth stocks seem to have regained their appeal this month. This is especially true given that the S&P 500 Growth Index is up 3.9% so far this month, outpacing the gain of 1.6% for the S&P 500 Value Index.
American economy has been on a solid growth path. This is especially true as U.S. GDP growth expanded 4.1% annually in the second quarter, representing the fastest pace of growth in nearly four years. The number is almost double the revised Q1 growth rate of 2.2%. With this, GDP expanded 3.1% for the first half of the year.Source: Gage Skidmore via Wikimedia (Modified)
While most of the ETFs will likely benefit on the astounding Q2 GDP numbers, we have highlighted five funds with a solid Zacks ETF Rank #1 (Strong Buy) or 2 (Buy) and expected to outperform in the days ahead.
The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month.Source: Shutterstock
E*TRADE Financial Corporation today announced it has surpassed 250 commission-free ETFs with the addition of 46 ETFs from six providers to its Commission-Free ETF Pr
Small-cap stocks and the corresponding exchange traded funds (ETFs) are on a tear. Over the past week, the widely followed Russell 2000 index is up nearly 3%, bringing its year-to-date gain to over 7%. By comparison, the large-cap S&P 500 is up just over 3% this year.
BioTelemetry’s (BEAT) net income has declined at a 3-year and 5-year average of 17% and 5.9% respectively. The company’s negative pre-tax margin changed from 5.5% in 2013 to 3.6% in 2017. The stock prices have beaten the diagnostics & research industry and S&P 500 between 2013 and 2017. The market cap had gained 373% between 2013 and 2017.
Wall Street has been on a roller-coaster ride this year. Yet, the small-cap segment of the broader market has been outperforming, defying extremely volatility. This is especially true as the Russell 2000 is nearing its record levels with just less than 1% away from its peak.Source: ShutterstockWhy Small Caps?
Small-cap stocks and the related exchange traded funds are often prized for their growth prospects and small-cap ETFs are explicitly dedicated to the growth factor, including the popular Vanguard Small-Cap ...
Although stocks have recently given back some of their short-term gains, the market big picture remains within the frame of momentum, which makes for a good environment to look to growth exchange-traded funds (ETFs).
The Zacks Analyst Blog Highlights: Select Sector SPDR Technology, Vanguard Small-Cap Growth, iShares MSCI ACWI, EventShares U.S. Tax Reform and Vanguard Value